1 active not recruiting, 1 not yet recruiting, 1 recruiting, 1 suspended. .
Follow OncoHost Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neutrophil Biomarker Test for Predicting Clinical Benefit From Immunotherapy Based on Flow Cytometry Analysis Blood sample collection - Non Small Cell Lung Cancer (NSCLC), Melanoma (Skin Cancer) | Not yet recruiting | OncoHost Ltd. | 600 | 2025-11-15 | 2025-11-24 | |
| Predicting Response Patterns to Treatment in Glioblastoma (GBM) Patients Glioblastoma | Suspended | OncoHost Ltd. | 1000 | 2023-01-01 | 2022-04-19 | |
| Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments, Using Multiomics blood, stool and tissue samples collection - Non Small Cell Lung Cancer, Healthy | Recruiting | OncoHost Ltd. | 350 | 2022-11-07 | 2023-02-21 | |
| Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments Plasma sample collection - Stage IV Non-small Cell Lung Cancer, Stage IV Malignant Melanoma | Active not recruiting | OncoHost Ltd. | 10000 | 2019-10-01 | 2026-10-19 |
Carcinoma, Non-Small-Cell Lung (3) · Melanoma (2) · Carcinoma, Renal Cell (1) · Glioblastoma (1) · Small Cell Lung Carcinoma (1) · Squamous Cell Carcinoma of Head and Neck (1) · Triple Negative Breast Neoplasms (1)
Blood Specimen Collection (1) · Defecation (1)
Germany (2) · Israel (2) · Spain (2) · United States (2) · Italy (1) · United Kingdom (1)
Abed Agbaria, MD (1) · Adam Berger, MD (1) · Adam Hassani (1) · Adam Hassani, MD (1) · Alexander Yakobson, MD (1) · Alison Brewster, MD (1) · Alona Zer, MD (1) · Andreas Polychronis, MD (1) · Andrew Conn, MD (1) · Anirban Chatterjee, MD (1) · Antony Magliocco, MD (1) · Ari VanderWalde, MD (1) · Astrid Ammendola, MD (1) · Bharat P Jenigiri, MD (1) · David Vecente, MD (1)